FIELD: process engineering.
SUBSTANCE: invention relates to production of minor spherical particles of active agent in sole liquid phase solution. Sole liquid phase comprises active agent, agent facilitating phase separation and first thinner. Phase separation is induced at controller rate in solution to cause separation active agent into "fluid-solid" and to form liquid and solid phases. Note here that inducing comprises solution cooling. Solid phase contains minor spherical particles of active agent. Liquid phase comprises agent facilitating phase separation and thinner. Minor spherical particles feature particle size varying from 0.01 mcm to about 200 mcm.
EFFECT: minor spherical particles of active agent in sole liquid phase solution.
77 cl, 49 dwg, 4 tbl, 36 ex
Title | Year | Author | Number |
---|---|---|---|
BIODEGRADABLE, SEMI-CRYSTALLINE, PHASE SEPARATED, THERMOPLASTIC MULTI-BLOCK COPOLYMERS FOR CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | 2012 |
|
RU2662818C2 |
MEDICINAL AGENTS WITH CONTROLLED RELEASE BASED ON BLOCK-COPOLYMERS | 2006 |
|
RU2409348C2 |
LONG-ACTING INSULIN COMPOSITION | 2010 |
|
RU2556340C2 |
COMPOSITION OF STABILIZED GROWTH HORMONE AND METHOD OF ITS PREPARING | 1997 |
|
RU2191029C2 |
MICROPARTICLE AND PHARMACEUTICAL COMPOSITION THEREOF | 2009 |
|
RU2490009C2 |
METHOD OF PURIFICATION OF CRUDE INSULIN OBTAINED FROM PIG PANCREAS | 1996 |
|
RU2126690C1 |
CONTRAST MEDIA TASTE MASKING FORMULATIONS | 2014 |
|
RU2683568C1 |
SKIN TREATMENT COMPOSITION CONTAINING HUMAN GROWTH HORMONES AS ACTIVE INGREDIENT | 2005 |
|
RU2401099C2 |
PEG-YLATED NANOPARTICLES | 2005 |
|
RU2400215C2 |
BIOLOGICAL ACTIVE AND/OR TARGET DENDRIMERIC CONJUGATES | 1995 |
|
RU2127125C1 |
Authors
Dates
2011-08-20—Published
2004-07-19—Filed